Table 2 Clinical stage distribution in two groups of patients studied
Tumour stage | Group A | Group B | Total | P value |
|---|---|---|---|---|
T1N0M0 | 3 (6.4%) | 1 (2.5%) | 4 (4.6%) | 0.621 |
T2N0M0 | 3 (6.4%) | 2 (5.0%) | 5 (5.7%) | 1.000 |
T2N1M0 | 9 (19.1%) | 12 (30.0%) | 21 (24.1%) | 0.238 |
T2N2M0 | 1 (2.1%) | 0 (0%) | 1 (1.1%) | 1.000 |
T3N0M0 | 12 (25.5%) | 8 (20.0%) | 20 (22.9%) | 0.541 |
T3N1M0 | 17 (36.2%) | 17 (42.5%) | 34 (39.1%) | 0.546 |
T3N2M0 | 2 (4.3%) | 0 (0%) | 2 (2.3%) | 0.497 |
Total | 47 (100%) | 40 (100%) | 87 (100%) | - |